Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marc Bary"'
Autor:
Pauline Trémeaux, Tiphaine Lenfant, Faroudy Boufassa, Asma Essat, Adeline Mélard, Marine Gousset, Olivier Delelis, Jean-Paul Viard, Marc Bary, Cécile Goujard, Christine Rouzioux, Laurence Meyer, Véronique Avettand-Fenoel
Publikováno v:
EBioMedicine, Vol 41, Iss , Pp 455-464 (2019)
Background: In the current context of research on HIV reservoirs, offering new insights into the persistence of HIV DNA in infected cells, which prevents viral eradication, may aid in identifying cure strategies. This study aimed to describe the esta
Externí odkaz:
https://doaj.org/article/186a9bd273494e24aa23cffb29377bfb
Autor:
Julie Bottero, Anders Boyd, Maud Lemoine, Fabrice Carrat, Joel Gozlan, Anne Collignon, Nicolas Boo, Philippe Dhotte, Brigitte Varsat, Gerard Muller, Olivier Cha, Nadia Valin, Jean Nau, Pauline Campa, Benjamin Silbermann, Marc Bary, Pierre-Marie Girard, Karine Lacombe
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92266 (2014)
BackgroundIn low hepatitis B virus (HBV)-prevalent countries, most HBV-infected persons are unaware of their status. We aimed to evaluate whether (i) previous HBV-testing, (ii) physicians decision to screen, and (iii) CDC's recommendations identified
Externí odkaz:
https://doaj.org/article/b9bd3cc2423241de82e7256fa7e726bb
Autor:
Christine Rouzioux, Asma Essat, Véronique Avettand-Fenoel, Adeline Melard, Olivier Delelis, Tiphaine Lenfant, Marc Bary, Marine Gousset, Jean-Paul Viard, Laurence Meyer, Faroudy Boufassa, Cécile Goujard, Pauline Trémeaux
Publikováno v:
EBioMedicine
EBioMedicine, 2019, 41, pp.455-464. ⟨10.1016/j.ebiom.2019.02.016⟩
EBioMedicine, Elsevier, 2019, 41, pp.455-464. ⟨10.1016/j.ebiom.2019.02.016⟩
EBioMedicine, 2019, 41, pp.455-464. ⟨10.1016/j.ebiom.2019.02.016⟩
EBioMedicine, Elsevier, 2019, 41, pp.455-464. ⟨10.1016/j.ebiom.2019.02.016⟩
International audience; BACKGROUND:In the current context of research on HIV reservoirs, offering new insights into the persistence of HIV DNA in infected cells, which prevents viral eradication, may aid in identifying cure strategies. This study aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3ac0d73fde87832e9c9efdfc9f9fa1
https://hal.science/hal-02348707/document
https://hal.science/hal-02348707/document
Autor:
Christine Rouzioux, David Ramirez, Serge Ivanoff, Marianne Burgard, Marc Bary, Christiane Deveau, Marie-Laure Chaix, Catherine Delamare, Anne Tachet
Publikováno v:
Journal of Medical Virology. 54:60-68
The predictive value of two methods for measuring HIV RNA concentration in plasma was assessed in relation to CD4 lymphocyte counts during the asymptomatic period of infection. The design was a retrospective longitudinal case-control study for a mean
Autor:
T Dusautoir, S Chevret, Françoise Barré-Sinoussi, Jean-Paul Viard, L Morand-Joubert, D. Vittecoq, F Audat, A Bismuth, Marc Bary, F. Heshmati
Publikováno v:
Proceedings of the National Academy of Sciences. 92:1195-1199
A randomized double-blind controlled trial was conducted to determine the efficacy of passive immunotherapy in the treatment of symptomatic human immunodeficiency virus (HIV) infection. This trial included 86 symptomatic patients randomized to receiv
Autor:
Marianne Burgard, Laurence Meyer, Marc Bary, Jean-François Delfraissy, Christine Rouzioux, Cécile Goujard, Daniel Sereni, Christiane Deveau, Jean-Baptiste Hubert, Jean-Paul Viard
Publikováno v:
The Journal of infectious diseases. 192(1)
Background. The objective of this work was to assess the role of human immunodeficiency virus (HIV) reservoirs in the risk of disease progression, by studying the relationship between HIV DNA level in peripheral blood mononuclear cells (PBMCs) and pr
Autor:
C. Doinel, Jean-Paul Viard, Anne-Marie Couroucé, D. Vittecoq, Marc Bary, P. Rouger, Françoise Barré-Sinoussi, B. Mattlinger, Jean-Jacques Lefrère, J.F. Bach, Christine Rouzioux
Publikováno v:
The Journal of infectious diseases. 165(2)
To assess the place of passive immunotherapy in the treatment of AIDS, a randomized study was conducted that evaluated the safety and short-term efficacy of serial transfusions of human immunodeficiency virus type 1 (HIV-1) seropositive plasma in 18